Study Comparing Orteronel Plus Prednisone in Participants With Metastatic Castration-Resistant Prostate Cancer.

NCT01193257 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1099

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Orteronel
DRUG: Prednisone
DRUG: Orteronel Placebo

Sponsor

Millennium Pharmaceuticals, Inc.